- Nachrichtendetail
-
13.05.2024 12:50:41 - dpa-AFX: *MERCK ANNOUNCES DISCONTINUATION OF VIBOSTOLIMAB AND PEMBROLIZUMAB COFORMULATION ARM OF PHASE 3 KEYVIBE-010 TRIAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 131,490 | 10.06.24 22:00:12 | +0,820 | +0,63% | 131,480 | 131,700 | 130,630 | 130,670 |
